Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00448110 · ClinicalTrials.gov registry record · Phase 3
Efficacy and Safety of IV Diclofenac (DIC075V) for Pain After Abdominal or Pelvic Surgery
A Phase 3 study of Pain, Postoperative, sponsored by Javelin Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 331
- Enrollment target
- 14
- Study locations
NCT00448110 is a Phase 3 study of Pain, Postoperative that has completed, run by Javelin Pharmaceuticals. The registered enrollment target is 331 participants, above the 270-participant average among 108 other Pain, Postoperative trials with a reported enrollment target (23% higher). The trial reports 14 study locations across 8 states.
The verdict
NCT00448110, a Phase 3 study of Pain, Postoperative, has completed, sponsored by Javelin Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 331 participants
- Enrollment target
- 14
- Study locations
Study Summary
This study will compare repeated intermittent IV dosing of diclofenac in patients with moderate to severe post-surgical pain from abdominal or pelvic surgery.
Conditions Studied
Interventions
- DRUG placebo
- DRUG Intravenous Diclofenac (DIC075V)
- DRUG Intravenous Ketorolac
Study Locations (14)
Alabama
- Alabama Clinical Therapeutics - Birmingham
- Eliza Coffee Memorial Hospital - Florence
- Drug Research and Analysis Corp. - Montgomery
- Helen Keller Hospital - Sheffield
Texas
- Clinical Research Center - Austin
- Memorial Hermann Healthcare System - Memorial City Hospital - Houston
- Clinical Research Center - San Marcos
California
- Glendale Adventist Medical Center - Glendale
- Saddleback Memorial Medical Center - Laguna Hills
Arkansas
- Teton Research / Parkview Surgical - Little Rock
Florida
- Visions Clinical Research - Boynton Beach
North Carolina
- Duke University Medical Center - Durham
North Dakota
- Clinical Research Services - Bismarck
Utah
- Jean Brown Research - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 331 participants |
| Start Date | 2006-05 |
| Est. Completion | 2007-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00448110
The ClinicalTrials.gov registry entry for NCT00448110 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 331 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 270-participant average among 108 other Pain, Postoperative trials with a reported enrollment target (23% higher). The listed sponsor is Javelin Pharmaceuticals, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pain, Postoperative appearing as the primary indexed condition, and to 3 interventions - of which placebo is the first listed.
NCT00448110 reports 14 study locations spanning 8 distinct geographic areas - top geographies include Alabama, Texas, California.
Frequently Asked Questions
What is clinical trial NCT00448110 about?
NCT00448110 is a clinical study titled "Efficacy and Safety of IV Diclofenac (DIC075V) for Pain After Abdominal or Pelvic Surgery". This study will compare repeated intermittent IV dosing of diclofenac in patients with moderate to severe post-surgical pain from abdominal or pelvic surgery.
What is the current status of trial NCT00448110?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 331 participants. The study started on 2006-05. Estimated completion is 2007-11.
What conditions does trial NCT00448110 study?
This clinical trial studies the following conditions: Pain, Postoperative.
What interventions are being tested in trial NCT00448110?
The interventions under investigation include: placebo (DRUG), Intravenous Diclofenac (DIC075V) (DRUG), Intravenous Ketorolac (DRUG).
Who is sponsoring clinical trial NCT00448110?
This trial is sponsored by Javelin Pharmaceuticals, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00448110 being conducted?
This trial has 14 study locations across Alabama, Arkansas, California, Florida, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain, Postoperative
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression
RECRUITING · Phase 3
-
Opioid-Free Orthopaedics
RECRUITING · Phase 3
-
Evaluate Efficacy and Safety of Extended Release (ER) Naproxen Sodium
COMPLETED · Phase 3
-
Bilateral Continuous Erector Spinae Blocks for Post-Sternotomy Pain Management: A Pilot Study
COMPLETED · Phase 3
-
Multicenter Study to Evaluate the Analgesic Efficacy of XP21L in Subjects With Pain Following Bunionectomy Surgery
COMPLETED · Phase 3
-
Safety and Clinical Utility Study of SSEC Fentanyl 40 mcg for Acute Post-op Pain Management in Pediatric Participants
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.